JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25 Stock JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25
Add to a list
To use this feature you must be a member
Log inSign up

JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25 Share Price

Warrant

DE000JS7PU57

Market Closed - Bid/Ask 10:21:08 28/06/2024 BST After market 20:36:54
0.005 EUR -16.67% Intraday chart for JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25 0.009 +80.00%
1 month+20.00%
3 months-78.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees MT
More news

Quotes 5-day view

Date Price Change
28/06/24 0.005 -16.67%
27/06/24 0.006 0.00%
25/06/24 0.006 0.00%
24/06/24 0.006 0.00%
21/06/24 0.006 0.00%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 10:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
Issuer J.P. Morgan
WKN JS7PU5
ISINDE000JS7PU57
Date issued 10/02/2023
Strike 75 $
Maturity 17/01/2025 (203 Days)
Parity 10 : 1
Emission price 0.92 €
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.87 €
Lowest since issue 0.003 €
Spread 0.01 €
Spread %71.43%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.51 USD
Average target price
53.19 USD
Spread / Average Target
+28.15%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant